Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
An overview of how weight decay factors into index performance and the practical implications for index-following strategies.
28,655 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Nexstar's chief executive warns that the era of local news funding through traditional ads may be ending. He says the...
As 2026 unfolds, a revival in wafer fab equipment spending arrives with tighter terms and higher tool prices, signali...
FIFA announced a record $871 million prize purse for the 2026 World Cup across 48 teams, with a $12.5 million baselin...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
A decade into AI-driven demand, Marvell and Micron have shown how long-term bets on data infrastructure and memory ca...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
Applied Materials reports a robust free cash flow figure for Q1 2026, but the stock fell as traders questioned how lo...
A six-year analysis ties CEO ego cues to push for in-person work, highlighting how office-first power dynamics influe...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...